Chiral HPLC analysis of milnacipran and its FMOC-derivative on cellulose-based stationary phases

Chirality

Volumn 20, Issue 2, 2008, Pages 63-68

  Patti, Angela ^a   Pedotti, Sonia ^a   Sanfilippo, Claudia ^a  

^a CNR   (Italy)

Author keywords

Cellulose based chiral stationary phase; Chiral drug; Enantioselective HPLC; Fmoc derivative; Milnacipran

Indexed keywords

CARBAMIC ACID; CELLULOSE; MILNACIPRAN;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHIRALITY; DERIVATIZATION; DRUG DETERMINATION; ENANTIOSELECTIVITY; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ANIMALS; CELLULOSE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOPROPANES; FLUORENES; HUMANS; OPTICS; STEREOISOMERISM;

EID: 38549117445     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.20496     Document Type: Article

References (23)

1. Moret C, Charveron M, Finberg JP, Briley M. Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethylaminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug. Neuropharmacology 1985;24:1211-1219.
2. Briley M. Milnacipran, a well-tolerated specific serotonin and norepinephrine reuptake inhibiting antidepressant. CNS Drug Rev 1998;4:137-148.
3. Shuto S, Takada H, Mochizuki D, Tsujita R, Hase Y, Ono S, Shibuya N, Matsuda A (±)-(Z)2-(aminomethyl)-1-phenylcyclopropanecarboxamide derivatives as a new prototype of NMDA receptor antagonists. J Med Chem 1995;38:2964-2968.
4. Leo RJ, Brooks V. Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain. Curr Opin Invest Drugs 2006;7:637-642.
5. Shuto S, Ono S, Hase Y, Kamiyama N, Matsuda A. Synthesis of (+)-and (-)-milnaciprans and their conformationally restricted analogs. Tetrahedron Lett 1996;37:641-644.
6. Doyle MP, Hu W. A new enantioselective synthesis of milnacipran and an analogue by catalytic asymmetric cyclopropanation. Adv Synth Catal 2001;343:299-302.
7. 2: a new base for stoichiometric, position-selective deprotonation of cyclopropanecarboxamides and other weak CH acids. Angew Chem Int Ed Engl 2002;41:2169-2171.
8. Roggen H, Kehler J, Stensbøl TB, Hansen T. Synthesis of enantiomerically pure milnacipran analogs and inhibition of dopamine, serotonin, and norepinephrine transportes. Bioorg Med Chem Lett 2007;17:2834-2837.
9. Puozzo C, Panconi E, Deprez D. Pharmacology and pharmacokinetics of milnacipran. Int Clin Psychopharmacol 2002:17;25S-35S.
10. Baker GB, Prior TI. Stereochemistry and drug efficacy and development: relevance of chirality to antidepressant and antipsychotic drugs. Ann Med 2002;34:537-543.
11. Marzo A, Heftmann E. Enantioselective analytical methods in pharmacokinetics with specific reference to genetic polymorphic metabolism. J Biochem Biophys Methods 2002;54:57-70.
12. Rentsch KM. The importance of stereoselective determination of drugs in the clinical laboratory. J Biochem Biophys Methods 2002;54:1-9.
13. Andersson S, Allenmark SG. Preparative chiral chromatographic resolution of enantiomers in drug discovery. J Biochem Biophys Methods 2002;54:11-23.
14. Lacassie E, Gaulier J-M, Parquet P, Rabatel J-F, Lachatre G. Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography. J Chromatogr B 2000;742:229-238.
15. Tournel G, Houdret N, Hédouin V, Deveaux M, Gosset D, Lhermitte M. High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum. J Chromatogr B 2001;761:147-158.
16. Puozzo C, Filaquier C, Zorza G. Determination of milnacipran, a serotonin and noradrenaline reuptake inhibitor, in human plasma using liquid chromatography with spectrofluorimetric detection. J Chromatogr B 2004;806:221-228.
17. Labat L, Deveaux M, Dallet P, Dubost JP. Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography. J Chromatogr B 2002;773:17-23.
18. Grard S, Morin P, Dreux M, Ribet J.-P. Enhancement of second-migrating enantiomer peak symmetry of basic drugs by using dual-cyclodextrin system in capillary electrophoresis. Electrophoresis 2000;21:3028-3034.
19. Q2B Validation of Analytical Procedures, ICH Sectretariat, November 1996 http://www.fda.gov/cder/guidance/1320fnl.pdf
20. Zhang T, Nguyen D, Franco P, Murakami T, Ohnishi A, Kurosawa H. Cellulose 3,5-dimethylphenylcarbamate immobilized on silica. A new chiral stationary phase for the analysis of enantiomers. Anal Chim Acta 2006;557:221-228.
21. Okamoto Y. Yashima E. Polysaccharide derivatives for cromatographic separation of enantiomers. Angew Chem Int Ed Engl 1998;37:1020-1043.
22. Matthijs N, Maftou M, Vander Heyden Y. Screening approach for chiral separation of pharmaceuticals. IV. Polar organic solvent chromatography. J Chromatogr A 2006;1111:48-61.
23. Jin JY, Lee W, Park JH, Ryoo JJ. Covalently bonded and coated chiral stationary phases derived from polysaccharide derivatives for enantiomer separation of N-fluorenylmethoxycarbonyl α-amino acids with fluorescence detection. J Liq Chromtogr Rel Technol 2006;29:1793-1801.